Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a recruitment notice indicating no longer looking for participants and introduced new participant guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated label for Intervention/Treatment. The page revision metadata now shows Revision: v3.6.0 (replacing v3.5.5).SummaryDifference0.3%

- Check15 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page metadata or content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display version change rather than a change to the clinical study details.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded the MeSH term 'Cutaneous neuroendocrine carcinoma' and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.